Angiogenesis and its modulation in the pathophysiology and treatment of endometrial carcinoma

Craig A. Mayr, June Yijuan Hou, Gary L. Goldberg, Dennis Yi-Shin Kuo

Research output: Contribution to journalArticle

Abstract

Endometrial cancer is the most common gynecologic malignancy in women. When detected early, this disease has a relatively good prognosis. However, advanced stage disease is associated with a poor outcome. Current therapies for advanced endometrial cancer include surgery, chemotherapy, radiotherapy, and hormonal therapy. Responses to these modalities are variable, but rarely exceed 20%. Angiogenesis plays a critical role in both the normal and the pathologic physiology of the human endometrium. Like a wide array of other tumors, the formation of new blood vessels to feed an enlarging tumor mass occurs in endometrial cancer. This review focuses on the role of angiogenesis and its inhibition in the pathophysiology and treatment of endometrial cancer.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalOncology Reviews
Volume5
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

Endometrial Neoplasms
Neoplasms
Therapeutics
Endometrium
Blood Vessels
Radiotherapy
Drug Therapy

Keywords

  • Angiogenesis
  • Antiangiogenesis therapy
  • Endometrial cancer
  • Endometrium

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Angiogenesis and its modulation in the pathophysiology and treatment of endometrial carcinoma. / Mayr, Craig A.; Hou, June Yijuan; Goldberg, Gary L.; Kuo, Dennis Yi-Shin.

In: Oncology Reviews, Vol. 5, No. 1, 03.2011, p. 43-48.

Research output: Contribution to journalArticle

Mayr, Craig A. ; Hou, June Yijuan ; Goldberg, Gary L. ; Kuo, Dennis Yi-Shin. / Angiogenesis and its modulation in the pathophysiology and treatment of endometrial carcinoma. In: Oncology Reviews. 2011 ; Vol. 5, No. 1. pp. 43-48.
@article{8616df5f862d4f609afca2227f7e0301,
title = "Angiogenesis and its modulation in the pathophysiology and treatment of endometrial carcinoma",
abstract = "Endometrial cancer is the most common gynecologic malignancy in women. When detected early, this disease has a relatively good prognosis. However, advanced stage disease is associated with a poor outcome. Current therapies for advanced endometrial cancer include surgery, chemotherapy, radiotherapy, and hormonal therapy. Responses to these modalities are variable, but rarely exceed 20{\%}. Angiogenesis plays a critical role in both the normal and the pathologic physiology of the human endometrium. Like a wide array of other tumors, the formation of new blood vessels to feed an enlarging tumor mass occurs in endometrial cancer. This review focuses on the role of angiogenesis and its inhibition in the pathophysiology and treatment of endometrial cancer.",
keywords = "Angiogenesis, Antiangiogenesis therapy, Endometrial cancer, Endometrium",
author = "Mayr, {Craig A.} and Hou, {June Yijuan} and Goldberg, {Gary L.} and Kuo, {Dennis Yi-Shin}",
year = "2011",
month = "3",
doi = "10.1007/s12156-010-0063-y",
language = "English (US)",
volume = "5",
pages = "43--48",
journal = "Oncology Reviews",
issn = "1970-5557",
publisher = "PagePress",
number = "1",

}

TY - JOUR

T1 - Angiogenesis and its modulation in the pathophysiology and treatment of endometrial carcinoma

AU - Mayr, Craig A.

AU - Hou, June Yijuan

AU - Goldberg, Gary L.

AU - Kuo, Dennis Yi-Shin

PY - 2011/3

Y1 - 2011/3

N2 - Endometrial cancer is the most common gynecologic malignancy in women. When detected early, this disease has a relatively good prognosis. However, advanced stage disease is associated with a poor outcome. Current therapies for advanced endometrial cancer include surgery, chemotherapy, radiotherapy, and hormonal therapy. Responses to these modalities are variable, but rarely exceed 20%. Angiogenesis plays a critical role in both the normal and the pathologic physiology of the human endometrium. Like a wide array of other tumors, the formation of new blood vessels to feed an enlarging tumor mass occurs in endometrial cancer. This review focuses on the role of angiogenesis and its inhibition in the pathophysiology and treatment of endometrial cancer.

AB - Endometrial cancer is the most common gynecologic malignancy in women. When detected early, this disease has a relatively good prognosis. However, advanced stage disease is associated with a poor outcome. Current therapies for advanced endometrial cancer include surgery, chemotherapy, radiotherapy, and hormonal therapy. Responses to these modalities are variable, but rarely exceed 20%. Angiogenesis plays a critical role in both the normal and the pathologic physiology of the human endometrium. Like a wide array of other tumors, the formation of new blood vessels to feed an enlarging tumor mass occurs in endometrial cancer. This review focuses on the role of angiogenesis and its inhibition in the pathophysiology and treatment of endometrial cancer.

KW - Angiogenesis

KW - Antiangiogenesis therapy

KW - Endometrial cancer

KW - Endometrium

UR - http://www.scopus.com/inward/record.url?scp=79954614802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954614802&partnerID=8YFLogxK

U2 - 10.1007/s12156-010-0063-y

DO - 10.1007/s12156-010-0063-y

M3 - Article

AN - SCOPUS:79954614802

VL - 5

SP - 43

EP - 48

JO - Oncology Reviews

JF - Oncology Reviews

SN - 1970-5557

IS - 1

ER -